Search results
Moderna’s Covid-19 vaccine meets primary efficacy endpoint in Phase III trial
Clinical Trials Arena via Yahoo Finance· 36 minutes agoModerna has announced that its Phase III clinical trial of the investigational next-generation Covid...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 13 hours ago(Getty Images) Vera Vita via Getty Images It’s summer 2024, but the COVID-19 pandemic is still...
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA Today· 14 hours agoCases of the latest COVID-19 variant, also known as KP.3, are on the rise in the United States....
Moderna says next-generation COVID vaccine efficacy non-inferior to current shot
Reuters via Yahoo News· 22 hours agoThe experimental vaccine, which met the main trial goal, was being tested in more than 11,000 people...
Is It Too Late to Buy Novavax Stock?
Motley Fool via Yahoo Finance· 14 minutes agoJust be aware that the bullishness only goes so far. The consensus analyst price target on the healthcare stock is $17.50, which is only about 9% higher...
Vaccine critics misrepresent US appeals court ruling over Covid-19 shots
AFP via Yahoo News· 3 days agoVaccine skeptics are claiming a US federal appeals court ruled in June 2024 that Covid-19 shots are...
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA Today· 4 days agoModerna said Monday that its combination vaccine against flu and COVID-19 drew a greater immune...
US government to fund up to $500 million for studies on oral, nasal COVID vaccines
Reuters via AOL· 11 hours agoBARDA, which helps companies develop medical supplies to address public health threats, is a part of HHS. The project is awarding up to $453 million to Vaxart for a study that will evaluate ...
No, study didn't blame COVID-19 vaccines for excess pandemic deaths | Fact check
USA Today· 2 days agoA June 5 Facebook post (direct link, archive link) claims a new study has revealed alarming news...
FDA advises Covid vaccine makers to target KP.2 for fall shots
NBC News via Yahoo News· 10 hours agoThe FDA advised drugmakers to update Covid vaccines to target the KP.2 strain, a descendant of the...
